Skip to main content
Livermore
Livermore
ZHEN

Sapient Capital LLC

SEC CIK
0001998653
Latest filing
Jul 9, 2026

The latest 13F from Sapient Capital LLC covers Q2 2026 (filed Jul 9, 2026): 396 long positions worth $7.64B. The top 10 holdings make up 64.7% of the portfolio, and the largest is Eli Lilly & Co (LLY) at 22.7%. Livermore has 14 filings on Form 13F from this institution, going back to Q4 2023.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
41
Est. +$70.7M
Added
103
Est. +$311.0M
Reduced
164
Est. −$380.4M
Sold out
88
Est. −$102.3M

Top 5 holdings

Share of this quarter's portfolio value

  1. LLYEli Lilly & Co
    22.7%$1.74BHistory
  2. Ea Series Trust02072Q192
    18.1%$1.38B
  3. APPAppLovin Corp
    7.5%$574.9MHistory
  4. AAPLApple Inc.
    4.4%$334.4MHistory
  5. GOOGLAlphabet Inc.
    2.9%$224.8MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. MSMorgan Stanley
    +$35.8MAddedHistory
  2. CHDNChurchill Downs Inc
    +$32.2MAddedHistory
  3. BKNGBooking Holdings Inc.
    +$28.6MAddedConverted for a 25-for-1 splitHistory
  4. STLDSteel Dynamics Inc
    +$26.5MAddedHistory
  5. ASNDAscendis Pharma A/S
    +$24.6MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. LLYEli Lilly & Co
    +2.70 pp20.0% → 22.7%History
  2. MUMicron Technology Inc
    +0.69 pp0.3% → 1.0%History
  3. TSMTaiwan Semiconductor Manufacturing Co Ltd
    +0.54 pp1.1% → 1.6%History
  4. MSMorgan Stanley
    +0.47 pp<0.1% → 0.5%History
  5. STLDSteel Dynamics Inc
    +0.44 pp0.9% → 1.3%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. APPAppLovin Corp
    −$80.2MReducedHistory
  2. HBNCHorizon Bancorp Inc
    −$40.3MReducedHistory
  3. EQTEQT Corp
    −$33.2MSold outHistory
  4. GEGeneral Electric Co
    −$28.4MReducedHistory
  5. HDHome Depot, Inc.
    −$17.6MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. MSFTMicrosoft Corp
    −0.53 pp2.7% → 2.1%History
  2. HBNCHorizon Bancorp Inc
    −0.50 pp0.5% → <0.1%History
  3. EQTEQT Corp
    −0.50 pp0.5% → 0.0%History
  4. INTUIntuit Inc.
    −0.31 pp0.3% → <0.1%History
  5. GEGeneral Electric Co
    −0.30 pp0.5% → 0.2%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$7.64B
+$1.01B (+15.3%) vs. prior quarter
Positions
396
−47 vs. prior quarter
Top 10 concentration
64.7%
Top 10 as share of value
Turnover
5.4%
Q2 2026, one quarter
Average holding period
9.0 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2023), so positions held before then are understated.

13F filings by quarter

11 quarters, going back to Q4 2023. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $7.64B (Q2 2026)

Q4 2023: $3.88BQ1 2024: $4.51BQ2 2024: $4.80BQ3 2024: $4.98BQ4 2024: $5.24BQ1 2025: $5.07BQ2 2025: $5.58BQ3 2025: $6.50BQ4 2025: $7.12BQ1 2026: $6.63BQ2 2026: $7.64B
Q4 2023Q2 2026
13F filings of Sapient Capital LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 9, 2026Amended396$7.64BLLYEa Series TrustAPPvs. Q1 2026SEC
Q1 2026Jun 22, 2026Amended443$6.63BLLYEa Series TrustAPPvs. Q4 2025SEC
Q4 2025Feb 5, 2026417$7.12BLLYAPPAAPLvs. Q3 2025SEC
Q3 2025Oct 17, 2025388$6.50BLLYAPPAAPLvs. Q2 2025SEC
Q2 2025Jul 9, 2025373$5.58BLLYAPPMSFTvs. Q1 2025SEC
Q1 2025Apr 15, 2025364$5.07BLLYAPPAAPLvs. Q4 2024SEC
Q4 2024Jan 29, 2025367$5.24BLLYAPPAAPLvs. Q3 2024SEC
Q3 2024Oct 11, 2024389$4.98BLLYAAPLMSFTvs. Q2 2024SEC
Q2 2024Jul 15, 2024364$4.80BLLYMSFTAAPLvs. Q1 2024SEC
Q1 2024Apr 22, 2024369$4.51BLLYAPPMSFTvs. Q4 2023SEC
Q4 2023Feb 6, 2024Amended383$3.88BLLYAAPLMSFT–SEC

13D and 13G filings

Companies where Sapient Capital LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Sapient Capital LLC does not currently report owning 5% or more of any company.

Latest filings

2 filings on file made by Sapient Capital LLC or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Sapient Capital LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
INTSIntensity Therapeutics, Inc.Jul 9, 202512:32 PM ET13G/A3.90%976.8K shares−3.50 ppfrom 7.40%Below 5%Jun 30, 2025SEC
INTSIntensity Therapeutics, Inc.Dec 30, 20245:21 PM ET13G7.40%1.01M sharesNewMar 31, 2024SEC